Highlights and Quick Summary
- Annual 3Y Total Assets Growth (CAGR) for 2022 was 1459.18% (a Infinity% increase from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Total Assets Growth (CAGR) of Design Therapeutics, Inc.
Most recent 3Y Total Assets Growth (CAGR)of DSGN including historical data for past 10 years.Interactive Chart of 3Y Total Assets Growth (CAGR) of Design Therapeutics, Inc.
Design Therapeutics, Inc. 3Y Total Assets Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | – | – | – | 1459.18% |
2021 | – | – | – | – | 0.0% |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology